Tag: not-obliged
-
U.S. FDA panel narrowly backs Cempra’s antibiotic solithromycin
The effectiveness of Cempra Inc’s antibiotic to treat community-acquired pneumonia outweighs the risk of liver injury, an advisory panel to the U.S. Food and Drug Administration narrowly concluded on Friday. The panel voted 7-6 that the drug, solithromycin, should be approved to treat the kind of pneumonia that recently affected U.S. presidential candidate Hillary Clinton.…
-
U.S. FDA panel narrowly backs Cempra’s antibiotic solithromycin
The effectiveness of Cempra Inc’s antibiotic to treat community-acquired pneumonia outweighs the risk of liver injury, an advisory panel to the U.S. Food and Drug Administration narrowly concluded on Friday. The panel voted 7-6 that the drug, solithromycin, should be approved to treat the kind of pneumonia that recently affected U.S. presidential candidate Hillary Clinton.…
-
Dinner with TV may be a recipe for less healthy meals
By Madeline Kennedy (Reuters Health) – Families that eat dinner with the TV on tend to eat less healthy food and to enjoy the meals less than families who leave the TV off, according to a recent U.S. study. “Family meals are protective for many aspects of child health,” lead author Amanda Trofholz said by…
-
Dinner with TV may be a recipe for less healthy meals
By Madeline Kennedy (Reuters Health) – Families that eat dinner with the TV on tend to eat less healthy food and to enjoy the meals less than families who leave the TV off, according to a recent U.S. study. “Family meals are protective for many aspects of child health,” lead author Amanda Trofholz said by…
-
FDA highlights liver safety issues in Cempra drug review
(Reuters) – Cempra Inc’s experimental drug to treat community acquired pneumonia, the kind suffered by presidential candidate Hillary Clinton recently, causes a potentially concerning rise in liver enzymes, according to a preliminary review by the U.S. Food and Drug Administration. The review, posted on the FDA’s website on Wednesday, comes two days ahead of a…
-
FDA highlights liver safety issues in Cempra drug review
(Reuters) – Cempra Inc’s experimental drug to treat community acquired pneumonia, the kind suffered by presidential candidate Hillary Clinton recently, causes a potentially concerning rise in liver enzymes, according to a preliminary review by the U.S. Food and Drug Administration. The review, posted on the FDA’s website on Wednesday, comes two days ahead of a…